510(k) Report

510(k) · Cleared

Cleared

N Latex LP (a)

K013128510(k) TraditionalCleared Jan 18, 2002121-day reviewClass II21 CFR 866.5600

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dade Behring, Inc. · DFC Lipoprotein, Low-Density, Antigen, Antiserum, Control

Cleared on Jan 18, 2002 as substantially equivalent to K000121 (Beckman Coulter, Inc., 2000) after a 121-day review. Its family tree reaches back 1 generation to 2000. 7 later devices descend from it.

Decided
Jan 18, 2002
Review
121 days
Class
Class II
Product code
DFC
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K000121 (2000). 7 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2005: 2 descendants cleared2003: 1 descendant cleared2014: 1 descendant cleared2013: 1 descendant cleared2007: 1 descendant cleared2008: 1 descendant clearedK000121 · Immage Immunochemistry System Lipoprotein (a) Lpax Reagent, Array System Lipoprotein (a) Lpa Reagent, Lipoprotein (a) Calib · Beckman Coulter, Inc. · 2000200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 3 descendants3 generations forward: 2 descendants K000121 · Immage Immunochemistry System Lipoprotein (a) Lpax Reagent, Array System Lipoprotein (a) Lpa Reagent, Lipoprotein (a) Calib · Beckman Coulter, Inc. · 20000
  1. Root · 1 generation backK000121 Immage Immunochemistry System Lipoprotein (a) Lpax Reagent, Array…Beckman Coulter, Inc. · 2000
  2. This deviceK013128 N Latex LP (a)Dade Behring, Inc. · 2002
  3. Descendant · cites it directly · 4 of its ownK030477 Diadexus Plac TestDiadexus, Inc. · 2003 · Recalled
  4. Descendant · 2 generations on · 2 of its ownK050029 Cardiompo TestPrognostix, Inc. · 2005
  5. Descendant · cites it directly · 1 of its ownK050487 Quantia LA (a)Biokit, S.A. · 2005
  6. Descendant · 2 generations on · 0 of its ownK141575 Plac Test for LP-PLA2 ActivityDiadexus, Inc. · 2014
  7. Descendant · 2 generations on · 0 of its ownK132400 LP (a) Calibrators, and LP (a) ControlsBiokit, S.A. · 2013

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2003: 12005: 22007: 12008: 12013: 12014: 1
2003high 2 (2005) · low 0 (2004)2026

Most influential descendants

Showing 5 of 7 · See all
  • K030477Diadexus Plac TestDiadexus, Inc. · 2003 · cites it directly4descendants
  • K050029Cardiompo TestPrognostix, Inc. · 2005 · 2 generations on2descendants
  • K050487Quantia LA (a)Biokit, S.A. · 2005 · cites it directly1descendant
  • K141575Plac Test for LP-PLA2 ActivityDiadexus, Inc. · 2014 · 2 generations on0descendants
  • K132400LP (a) Calibrators, and LP (a) ControlsBiokit, S.A. · 2013 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K000121Immage Immunochemistry System Lipoprotein (a) Lpax Reagent, Array System…Beckman Coulter, Inc.2000—
0 (this device)K013128N Latex LP (a)Dade Behring, Inc.2002—
+1K030477Diadexus Plac TestDiadexus, Inc.20032
+2K050029Cardiompo TestPrognostix, Inc.2005—
+1K050487Quantia LA (a)Biokit, S.A.2005—
+2K141575Plac Test for LP-PLA2 ActivityDiadexus, Inc.2014—
+2K132400LP (a) Calibrators, and LP (a) ControlsBiokit, S.A.2013—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
200520
200710
200810
201310
201410
FIG. 1 — Lineage of K013128, 2000–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DFC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DFC device

  1. #1 K253069 Lipoprotein (a) Molarity Assayscore 11.5 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K000121Immage Immunochemistry System Lipoprotein (a) Lpax Reagent, Array System Lipoprotein (a)…
Summary page 1
…poprotein immunological test system, Class Il (866.5600) Product Code: 81 DFC 3. Identification of the Legally Marketed Device: Beckman Coulter Array® System LPA assay (K000121) 4, Device Description: Polystyrene latex particles coated with specific antibodies to human Lp(a) are agglutinated when mixed w…
Beckman Coulter, Inc.2000—

Also cleared against K000121: 1 other device →

What descends from it? (7)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K030477Diadexus Plac TestDiadexus, Inc.20034
K050487Quantia LA (a)Biokit, S.A.20051

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K030477 (Diadexus, Inc., 2003) has gone furthest, with 4 descendants of its own.
  • 1 other device also cites its predicate K000121.

How does its category compare?

All DFC devices

DFC Lipoprotein, Low-Density, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DFC

1in 2025

2007: 12009: 12012: 22018: 12022: 12025: 12026 (partial year): 1
2007high 2 (2012) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DFC

Too few DFC 510(k)s in any year since 2007 to give a median.

Recalls per year · DFC

2in 2024

2012: 12024: 2
2007high 2 (2024) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DFC

7in 2025

2016: 12023: 62024: 162025: 7
2007high 16 (2024) · low 0 (2007)2025

MAUDE reports naming product code DFC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20091—00
20100—00
20110—00
20122—10
20130—00
20140—00
20150—00
20160—01
20170—00
20181—00
20190—00
20200—00
20210—00
20221—00
20230—06
20240—216
20251—07
20261—0—

What is it indicated for?

N Latex Lp(a) Reagent is an in vitro diagnostic test for the quantitative determination of Lipoprotein(a) [Lp(a)] in human serum or plasma.

N Latex Lp(a) aids in the diagnosis of disorders of lipid (fat) metabolism and helps to identify persons at risk from cardiovascular disease in specific populations when used in conjunction with clinical evaluation.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K013128: N Latex LP (a).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K013128

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026